Drugs Made In America Acquisition Corp. Ordinary Shares Cash Flow Reinvestment Rate
Drugs Made In America Acquisition Corp. Ordinary Shares cash flow reinvestment rate. Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) has a Cash Flow Reinvestment Rate of 0.00x as of September 2025, reinvesting $4.00 (capex $4.00 ) from operating cash flow of $137.91K. Explore Drugs Made In America Acquisition Corp. (DMAA) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Drugs Made In America Acquisition Corp. Ordinary Shares Cash Flow Reinvestment Rate by Year (None–None)
Drugs Made In America Acquisition Corp. Ordinary Shares cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Drugs Made In America Acquisition Corp. Ordinary Shares. For the full cash flow conversion analysis, see Drugs Made In America Acquisition Corp. operating cash flow efficiency.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|